Aspirin was found to partially inhibit platelet-mediated cancer cells invasion [10] and proliferation [11], while other antiplatelet agents including a COX-2 inhibitor, an EP3 (PGE2 receptor) inhibitor and a P2Y12 receptor antagonist were found to interfere with platelet promotion of cancer [12]. Here, PTGER3 is linked to cancer.